Prot#A1481123: A Rdmzd, Dbl-blind, Dbl-dummy, Placebo-Controlled, Fixed Dose, Multi-Center Study to Evaluate Efficacy, Safety & Toleration of Oral Sildenafil Administered for 12 Weeks to Premenopausal Women Who Have Been Diagnosed w/ Fe

Project: Research project

Project Details

Effective start/end date11/27/021/1/11


  • Covance Periapproval Services, Inc. (A1481123 // A1481123)
  • Pfizer Global Research and Development (A1481123 // A1481123)